Adenocarcinoma of the Esophagus Terminated Phase 2 Trials for Arsenous acid (DB04456)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061958Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal JunctionTreatment